Results 81 to 90 of about 49,177 (212)

Overcoming barriers to effective management of tardive dyskinesia

open access: yes, 2019
Stanley N Caroff Corporal Michael J Crescenz VA Medical Center, and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Abstract: Tardive dyskinesia (TD) is a heterogeneous syndrome of involuntary hyperkinetic movements ...
Caroff SN
core  

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis [PDF]

open access: yes, 2000
Objective To develop an evidence base for recommendations on the use of atypical antipsychotics for patients with schizophrenia.Design Systematic overview and meta-regression analyses of randomised controlled trials, as a basis for formal development of ...
Freemantle, Nick   +5 more
core   +1 more source

Regions of reduced gray matter volume in schizophrenia with tardive dyskinesia group compared with schizophrenia without tardive dyskinesia group.

open access: yes, 2013
Regions of reduced gray matter volume in schizophrenia with tardive dyskinesia group compared with schizophrenia without tardive dyskinesia group.
Ya-Mei Bai (129526)   +6 more
core   +1 more source

A Case of Tardive Akathisia and Dyskinesia [PDF]

open access: yesDüşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2007
Various drugs, mainly antipsychotics in psychiatry may induce movement disorders. These acute or tardive type movement disorders could either be in hypokinetic or in hyperkinetic form. There are other movement disorders in tardive type (e.g.
Timuçin Oral   +4 more
doaj  

Therapeutic Trials in Tardive Dyskinesia

open access: yes, 1978
The search for a treatment of tardive dyskinesia has generally been guided by the putative biochemical mechanisms underlying the extrapyramidal disorders, but no markedly effective treatment has yet been found.
Andre Villeneuve
core   +1 more source

Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations

open access: yes, 2014
Tardive dyskinesia (TD) is a disfiguring side-effect of antipsychotic medications that is potentially irreversible in affected patients. Newer atypical antipsychotics are felt by many to have a lower risk of TD.
Thomas L Schwartz   +2 more
core   +1 more source

Clozapine-induced tardive dyskinesia: A case report

open access: yes, 2005
Purpose: Clozapine is indicated in the treatment of patients with tardive dyskinesia. However, there have been some reports of movement disorders associated with clozapine treatment in the literature.
Ertugrul, AYGÜN, DEMIR, B
core   +1 more source

Amisulpiride induced tardive dyskinesia: a case report [PDF]

open access: yes, 2018
Amisulpride is a bezamide group of antipsychotic, and like other antipsychotics, it acts by reducing signalling via the dopamine D2 receptor. It is associated with a high risk, of developing increased blood levels of the lactation hormone, prolactin and ...
Gupta, Kunjan   +2 more
core   +1 more source

Olanzapine-induced tardive oculogyric crises

open access: yesIndian Journal of Psychological Medicine, 2013
Tardive syndromes are much lower in prevalence in second generation antipsychotics (SGA) than in the typical antipsychotics. Although, olanzapine, which is an SGA, has a high risk of causing weight gain, metabolic syndrome, raised blood sugar, and ...
Amar D Bavle, Girish M. N. Kumar
doaj   +1 more source

Prevalence and Clinical Correlates of Tardive Dyskinesia in Patients with Chronic Mental Illness in Psychiatry Rehabilitation Centres

open access: yesOnline Journal of Health & Allied Sciences
Tardive Dyskinesia (TD) is a medication induced movement disorder characterised by involuntary athetoid or choreiform movements generally of the tongue, lower face and jaw, and extremities developing in association with the use of a neuroleptic ...
Bhanu Dahiya   +3 more
doaj  

Home - About - Disclaimer - Privacy